As a result of the suspicions that he delivered the thrombosis through the administration of the AstraZeneca vaccine, he would like to record that he was involved in drug dealing with the thrombocytopenia induced by pharmacists (TCPIF). TCPIF patients present with a reduction in plaque count of 5 to 10 days after pharmacy administration with a hemorrhagic risk mayor.
The diagnosis, in addition, is a challenge, because the majority of hospitalized patients have multiple medications and have comorbidities that can also cause thrombocytopenia.